SOD1

Across TCGA pan-cancer cohorts, SOD1 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated SOD1 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher SOD1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SOD1 expression acts as an unfavorable survival marker.

HNSC, SKCM, and ESCA are the cancer types where SOD1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.069	0.768	<.001	24	view →
SKCM	OS	Median	All	0.179	0.781	<.001	12	view →
ESCA	OS	Median	II,III,IV	0.216	0.702	.014	6	view →
COAD	OS	Median	III,IV	0.239	0.791	.014	6	view →
LUSC	OS	Median	All	0.011	0.819	<.001	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

SOD1–HNSC (OS)

Open the HNSC breakdown →